Résumé
The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.
Sujets)
Adolescent , Inhibiteurs de l'angiogenèse/administration et posologie , Anticorps monoclonaux/administration et posologie , Anticorps monoclonaux humanisés , Maladies de la choroïde/complications , Maladies de la choroïde/anatomopathologie , Néovascularisation choroïdienne/diagnostic , Néovascularisation choroïdienne/traitement médicamenteux , Néovascularisation choroïdienne/étiologie , Cicatrice/complications , Cicatrice/anatomopathologie , Femelle , Angiographie fluorescéinique , Fond de l'oeil , Humains , Injections intravitréennes , Rétinopathies/complications , Rétinopathies/anatomopathologie , Tomographie par cohérence optique , Toxoplasmose oculaire/complicationsRésumé
We report a case of central retinal vein occlusion (CRVO) following Sirsasana, a head-down postural yoga. A 55-year-old male patient presented to us, with sudden-onset loss of vision following Sirsasana, in the right eye. The patient had suffered from pulmonary thromboembolism 5 years earlier and was receiving warfarin prophylaxis. Over 6 months of follow-up, the patient developed neovascularization of the iris and was subjected to panretinal laser with no improvement in visual acuity. Sirsasana could be an important risk factor for CRVO especially in predisposed patients.